Clinical effectiveness and cost effectiveness of influenza vaccination among healthy working adults

Vaccine

Volumn 17, Issue SUPPL. 1, 1999, Pages

  Nichol, Kristin L ^a  

^a VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

CLINICAL TRIAL; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DRUG COST; DRUG EFFICACY; EMPLOYEE; HUMAN; INFLUENZA; INFLUENZA VACCINATION; PRIORITY JOURNAL;

ADULT; CLINICAL TRIALS; COST-BENEFIT ANALYSIS; HUMANS; IMMUNIZATION PROGRAMS; INFLUENZA, HUMAN;

EID: 0033618339     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00110-3     Document Type: Conference Paper

References (27)

1. Centers for Disease Control, Prevention 1998 Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Vol. 47(RR-6).
2. Couch RB, Advances in influenza virus vaccine research, Ann NY Acad Sci 1993;803-812.
3. Sullivan KM, Monto AS, Longini Jr IM. Estimates of the US health impact of influenza. Am J Public Health 1993;83:1712-6.
4. Riddiough MA, Sisk JE, Bell JC. Influenza vaccination: Cost-effectiveness and public policy. J Am Med Assoc 1983;249:3189-95.
5. Detsky AS, Nalie G. A clinician's guide to cost-effectiveness analysis. Ann Intern Med 1990;113:147-54.
6. Haddix AC, Shaffer PA. Cost-effectiveness analysis. In: Haddix AC, Teutsch SM, Shaffer PA, Dunet DO, editors. Prevention effectiveness. A guide to decision analysis and economic evaluation. New York: Oxford University Press, 1996. p. 103-29.
7. Owens DK. Interpretation of cost-effectiveness analyses. J Gen Intern Med 1998;13:716-7.
8. Azimi NA, Welch HG. The effectiveness of cost-effectiveness analysis in containing costs. J Gen Intern Med 1998;13:664-9.
9. Davenport F. Control of influenza. Med J Aust 1973;1(suppl.):33-8.
10. Meiklejohn G. Viral respiratory disease at Lowry Air Force Base in Denver, 1952-1982. J Infect Dis 1983;148:775-84.
11. Hammond ML, Ferris AA, Faine S, et al. Effective protection against influenza after vaccination with subunit vaccine. Med J Aust 1978;1:301-3.
12. Keitel WA, Cate TR, Couch RB. Efficacy of sequential annual vaccination with inactivated influenza virus vaccine. Am J Epidemiol 1986;127:353-64.
13. Edwards KM, Dupont WD, Westrich MK, et al. A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease. J Infect Dis 1994;169:68-76.
14. Couch RB, Keitel WA, Cate TR, et al. Prevention of influenza virus infections by current inactivated influenza virus vaccines. In: Brown LE, Hampson AW, Webster RB, editors. Options for the control of influenza, III. Amsterdam: Elsevier, 1996. p. 97-106.
15. Edmondson Jr WP, Rothenberg R, White PW, Gwaltney Jr JM. A comparison of subcutaneous, nasal, and combined influenza vaccination. II. protection against natural challenge. Am J Epidemiol 1971;93:480-6.
16. Edmondson KW, Graham DSM, Warburton MF. A clinical trial of influenza vaccine in Canberra. Med J Aust 1970;2:6-13.
17. Weingarten S, Staniloff H, Ault M, et al. Do hospital employees benefit from the influenza vaccine? A placebo-controlled trial. J Gen Intern Med 1988;3:32-7.
18. Batey D. A case study of influenza vaccine and its impact on absenteeism in the work place: A randomized clinical trial at Exxon Company, USA. In: Presented at a work group meeting on improving the performance of influenza and pneumococal vaccines in older adults, 1995 Washington DC, 14-15 November.
19. Nichol KL, Lind A, Margolis KL, et al. The effectiveness of vaccination against influenza in healthy, working adults. N Engl J Med 1995;333:889-93.
20. Smith JWG, Pollard R. Vaccination against influenza: Five-year study in the Post Office. J Hyg Camb 1979;83:157-70.
21. Grotto YM, Green MS, Varsano N, et al. Influenza vaccine efficacy in young, healthy adults. Clin Infect Dis 1998;26:913-7.
22. Leighton L, Williams M, Aubery D, Parker SH. Sickness absence following a campaign of vaccination against influenza in the workplace. Occup Med 1996;46:146-50.
23. Kavet JA. Perspective on the significance of pandemic influenza. Am J Public Health 1977;67:1063-70.
24. Smith AP, Marie T, Brockman P, et al. Effect of influenza virus B infection on human performance. Br Med J 1993;306:760-1.
25. Clements DA, Langdon L, Bland C, Walter E. Influenza A vaccine decreases the incidence of otitis media in 6 to 30-month-old children in day care. Arch Pediatr Adolesc Med 1995;149:1113-7.
26. Heikkinen T, Ruuskanen O, Waris M, et al. Influenza vaccination in the prevention of acute otitis media in children. Am J Dis Child 1991;145:445-8.
27. Belshe RB, Mendelman PM, Treanor J, et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N Engl J Med 1998;338:1405-12.